Cardiac markers in acute coronary syndromes - Refining our knowledge

European Heart Journal

Volumn 24, Issue 2, 2003, Pages 136-137

  Califf, R M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; TROPONIN;

CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DISEASE MARKER; EDITORIAL; HEART MUSCLE ISCHEMIA; HUMAN; INFLAMMATION; MEASUREMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; TISSUE INJURY;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY DISEASE; HUMANS; SYNDROME; TROPONIN;

EID: 0037257525     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-668X(02)00798-4     Document Type: Editorial

References (10)

1. Ohman EM, Armstrong PW, Christenson RH et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIa Investigators. N Engl J Med 1996;335:1333-41.
2. Newby LK, Christenson RH, Ohman EM et al. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. Circulation 1998;98:1853-9.
3. Antman EM, Tanasijevic MJ, Thompson B et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;335:1342-9.
4. Boersma E, Pieper KS, Steyerberg EW et al. Predictors of outcomes in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation 2000;101:2557-67.
5. Savonitto S, Ardissino D, Granger CB et al. Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA 1999;281:707-13.
6. Morrow DA, Antman EM, Charlesworth A et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an InTIME II trial substudy. Circulation 2000;102:2031-7.
7. Patel VB, Robbins MA, Topol EJ. C-reactive protein: a 'golden marker' for inflammation and coronary artery disease. Cleve Clin J Med 2001;68:521-4. [p. 527-34].
8. Antman EM. Decision making with cardiac troponin tests. N Engl J Med 2002;346:2079-82.
9. Lenderink T, Boersma E, Heeschen C et al. Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA. Eur Heart J 2003;24:77-85.
10. Oldgren J, Wattentin L, Grip L et al. Myocardial damage, inflammation and thrombin inhibition in unstable coronary artery disease. Eur Heart J 2003;24:86-93.